An Interim Safety Analysis of Combination Stereotactic Ablative Body Radiotherapy (SABR) with Adjuvant Anti-PD1 Immunotherapy in Oligometastatic Renal Cell Carcinoma

被引：0
|
作者：
Siva, Shankar [1 ,2 ,3 ]
Bressel, Mathias [1 ]
Sandhu, Shahneen [1 ]
Tran, Ben [1 ]
Mooi, Jennifer [1 ]
Lewin, Jeremy [1 ]
Loi, Sherene [1 ,2 ,3 ]
Toner, Guy [1 ,2 ,3 ]
Moon, Daniel [1 ]
Goad, Jeremy [1 ]
Shaw, Mark [1 ]
Chander, Sarat [1 ]
Eade, Thomas [4 ]
Guminksi, Alex [4 ]
Dasantha, Jayamanne [4 ]
Pryor, David [5 ]
Cuff, Katherine [5 ]
Wood, Simon [5 ]
Lawrentschuk, Nathan [1 ]
Murphy, Declan [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Northern Sydney Canc Ctr, Sydney, NSW, Australia
[5] Princess Alexandra Hosp, Brisbane, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs19
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [21] SAFETY AND EFFICACY OF STEREOTACTIC ABLATIVE BODY RADIOTHERAPY FOR PRIMARY RENAL CELL CARCINOMA (RCC): PRINCIPAL ANALYSIS OF THE FASTRACK CLINICAL TRIAL
    Siva, Shankar
    Kron, Tomas
    Bressel, Mathias
    Parameswaran, Bimal
    Shaw, Mark
    Gill, Suki
    Pham, Daniel
    Lam, Jaqueline
    Jackson, Price
    Tai, Keen-Hun
    Violet, John
    Tan, Teng Han
    Chesson, Brent
    Goad, Jeremy
    Murphy, Declan
    Lawrentschuk, Nathan
    Lau, Eddie
    Foroudi, Farshad
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 29 - 29
  • [22] Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma
    Reynolds, Hayley M.
    Parameswaran, Bimal K.
    Finnegan, Mary E.
    Roettger, Diana
    Lau, Eddie
    Kron, Tomas
    Shaw, Mark
    Chander, Sarat
    Siva, Shankar
    PLOS ONE, 2018, 13 (08):
  • [23] Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma
    Guler, Ozan Cem
    Oymak, Ezgi
    Hurmuz, Pervin
    Yavas, Guler
    Tilki, Burak
    Yavas, Cagdas
    Ozyigit, Gokhan
    Onal, Cem
    UROLOGIA INTERNATIONALIS, 2023, 107 (02) : 171 - 178
  • [24] Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach
    Agolli, Linda
    Valeriani, Maurizio
    Nicosia, Luca
    Bracci, Stefano
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Enrici, Riccardo Maurizi
    Osti, Mattia Falchetto
    ANTICANCER RESEARCH, 2015, 35 (11) : 6239 - 6245
  • [25] Outcomes of Primary Tumor Stereotactic Ablative Body Radiotherapy for Localized and Metastatic Renal Cell Carcinoma
    Huang, D.
    Lynch, C.
    Serra, L. M.
    Sweis, R. F.
    Stadler, W. M.
    Szmulewitz, R. Z.
    O'Donnell, P. H.
    Chang, P. J.
    Eggener, S. E.
    Shalhav, A. I.
    Liauw, S.
    Pitroda, S. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E538 - E538
  • [26] A SINGLE INTRATUMORAL ANTI-PD1 THERAPY WITH ADJUVANT ABLATIVE FRACTIONAL LASER INCREASES THE IMMUNE CELL INFILTRATION IN BASAL CELL CARCINOMA
    Omland, Silje
    Ejlertsen, Jacob
    Krustrup, Dorrit
    Christensen, Rikke
    Olesen, Uffe Hogh
    Haedersdal, Merete
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 42 - 42
  • [27] Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma
    Huang, Daniel
    Lynch, Connor
    Serra, Lucas M.
    Sweis, Randy F.
    Chang, Paul J.
    Stadler, Walter M.
    Szmulewitz, Russell Z.
    O'Donnell, Peter H.
    Sidana, Abhinav
    Eggener, Scott E.
    Shalhav, Arieh L.
    Liauw, Stanley L.
    Pitroda, Sean P.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 49
  • [28] Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser
    Omland, Silje Haukali
    Ejlertsen, Jacob Secher
    Krustrup, Dorrit
    Christensen, Rikke Louise
    Svane, Inge Marie
    Olesen, Uffe Hoegh
    Haedersdal, Merete
    CANCERS, 2022, 14 (23)
  • [29] Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes
    Bates, James E.
    De Leo, Alexandra N.
    Morris, Christopher G.
    Amdur, Robert J.
    Dagan, Roi
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (07): : 2309 - 2314
  • [30] Stereotactic Body Radiotherapy for Renal Cell Carcinoma-A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings
    Villafuerte, Conrad Josef Q.
    Swaminath, Anand
    CANCERS, 2024, 16 (19)
12345